Equity Overview
Price & Market Data
Price: $1.00
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $1,235,060
Daily Volume: 0
Performance Metrics
1 Week: -25.37%
1 Month: -25.37%
3 Months: 234.2%
6 Months: 323.4%
1 Year: 352.5%
YTD: 234.2%
About Noveris Health Sciences Inc. (MYCOF)
Essential market data for Noveris Health Sciences Inc. (MYCOF). The stock is trading at 1.00, with a daily change of $0.00 / 0.00%. Market cap: 1,235,060. Review its performance across all major time intervals.
Details
Noveris Health Sciences Inc., a biotechnology company, engages in the research, development, and commercialization of psilocybin products to treat mental health conditions. The company primarily focuses on treating nicotine addiction and post-traumatic stress disorder. It also develops MYCO-005, MYCO-006, and MYCO-007 for MDMA and psilocybin analogs. The company has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entactogenic compounds. Noveris Health Sciences Inc. was formerly known as Mydecine Innovations Group Inc. and changed its name to Noveris Health Sciences Inc. in February 2026. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.